Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy
Go back to Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 47.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.17 | 52 Week High | $59.00 | |||
| Open | $47.17 | 52 Week Low | $32.80 | |||
| Day High | $47.17 | P/E | N/A | |||
| Day Low | $47.17 | EPS | $0.00 | |||
| Volume | 385,630 | |||||

